A review of hemoglobin and the pathogenesis of cerebral vasospasm

Stroke

Volumn 22, Issue 8, 1991, Pages 971-982

  Macdonald, R Loch ^a   Weir, Bryce K A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cerebral arteries; Cerebral vasospasm; Hemoglobin; Subarachnoid hemorrhage

Indexed keywords

ENDOTHELIN; HEMOGLOBIN; ICOSANOID;

BRAIN ARTERY; DOG; HEMOLYSIS; HUMAN; MONKEY; NONHUMAN; PRIORITY JOURNAL; RABBIT; REVIEW; VASOSPASM;

CEREBRAL ARTERIES; HEMOGLOBINS; HUMAN; ISCHEMIC ATTACK, TRANSIENT; OXYHEMOGLOBINS; SUBARACHNOID HEMORRHAGE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VASOCONSTRICTION;

EID: 0025779483     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.22.8.971     Document Type: Article

References (201)

1. Weir B, Rothberg C, Grace M, Davis F: Relative prognostic significance of vasospasm following subarachnoid hemorrhage. Can J Neuml Sci 1975;2:109-114
2. Heros RC, Zervas NT, Varsos V: Cerebral vasospasm after subarachnoid hemorrhage: An update. Ann Neurol 1983;14:599-608
3. Kassell NF, Sasaki T, Colohan ART, Nazar G: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985;16:562-572
4. Haley EC, Tomer JC, Kassell NF, and participants: Cooperative randomized study of nicardipine in subarachnoid hemorrhage: Preliminary report, in Sano K, Takakura K, Kassell NF, Sasaki T (eds): Cerebral Vasospasm. Tokyo, University of Tokyo Press, 1991, pp 519-525
5. Weir BKA: Anewysms Affecting the Nervous System. Baltimore, Williams & Wilkins Co, 1987, pp 505-569
6. Macdonald RL, Weir BKA, Runzer TD, Grace MGA, Findlay JM, Saito K, Cook DA, Mielke BW, Kanamaru K; Etiology of cerebral vasospasm in primates. J Neurosurg (in press)
7. Osaka K, Handa H, Okamoto S: Subarachnoid erythrocytes and their contribution to cerebral vasospasm, in Wood JH (ed): Newobiology of Cerebrospinal Fluid. New York, Plenum PTess, 1980, pp 313-323
8. Misra HP, Fridovich I: The generation of superoxide radical during the autoxidation of hemoglobin. J Biol Chem 1972;247:6960-6962
9. Asano T, Tanishima T, Sasaki T, Sano K: Possible participation of free radical reactions initiated by clot lysis in the pathogenesis of vasospasm after subarachnoid hemorrhage, in Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins Co, 1980, pp 190-201
10. Duff TA, Feilbach JA, Yusuf Q, Scott G: Bilirubin and the induction of intracranial arterial spasm. J Neurosurg 1988;69:593-598
11. Miao FJP, Lee TJF: Effects of bilirubin on cerebral arterial tone in vitro. J Cereb Blood Flaw Metab 1989;9:666-674
12. Toda N: Mechanisms of contracting action of oxyhemoglobin in isolated monkey and dog cerebral arteries. Am J Physiol 1990;258:H57-H63
13. Machi T, Stewart D, Kassell NF, Comair Y, Nihei H, Tanaka Y: Hemoglobin enhances release of endothelin from cultured bovine endothelial cells, in Sano K, Takakura K, Kassell NF, Sasaki T (eds): Cerebral Vasospasm. Tokyo, University of Tokyo Press, 1991, pp 262-265
14. Endo S, Hori S, Suzuki J: Experimental cerebral vasospasm and sympathetic nerve. Neurol Med Chir (Tokyo) 1977;17(part II):313-326
15. Okada H, Endo S, Kamiyama K, Suzuki J: Oxyhemoglobininduced cerebral vasospasm and sequential changes in vascular ultrastructure. Neurol Med Chir (Tokyo) 1980;20:573-582
16. Martin W, Villani GM, Jothianandan D, Furchgott RF: Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985;232: 708-716
17. Barrows LJ, Hunter FT, Banker BQ: The nature and clinical significance of pigments in the cerebrospinal fluid. Brain 1955;78:59-80
18. Osaka K: Prolonged vasospasm produced by the breakdown products of erythrocytes. J Neurosurg 1977;47:403-411
19. Miyaoka M, Nonaka T, Watanabe H, Chigasaki H, Ishii S: Etiology and treatment of prolonged vasospasm: Experimental and clinical studies. Neurol Med Chir (Tokyo) 1976;16:103-114
20. Sonobe M, Suzuki J: Vasospasmogenic substance produced following subarachnoid haemorrhage, and its fate. Acta Neurochir (Wien) 1978;44:97-106
21. Sasaki T, Tanishima T, Asano T, Mayanagi Y, Sano K: Significance of lipid peroxitiation in the genesis of chronic vasospasm following rupture of an in tracranial aneurysm. Acta Natwchir Suppl (Wien) 1979;28:536-540
22. Okwuasaba F, Cook D, Weir B: Changes in vasoactive properties of blood products with time and attempted identification of the spasmogens. Stroke 1981;12:775-780
23. Duff TA, Feilbach JA, Scott G: Does cerebral vasospasm result from denervation supersensitivity? Stroke 1987;18:85-91
24. Roost KT, Pimstone NR, Diamond I, Schmid R: The formation of cerebrospinal fluid xanthochromia after subarachnoid hemorrhage: Enzymatic conversion of hemoglobin to bilirubin by the arachnoid and choroid plexus. Neurology 1972;22:973-977
25. Wolkoff AW, Chowdhury JR, Arias IM: Hereditary jaundice and disorders of bilirubin metabolism, in Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL, Brown MS (eds): The Metabolic Basis of Inherited Disease, ed 5, New York, McGraw-Hill Book Co, 1983, pp 1385-1420
26. Findlay JM, Weir BKA, Kanamaru K, Grace M, Gordon P, Braughman R, Howarth A: Intrathecal fibrinolytic therapy after subarachnoid hemorrhage: Dosage study in a primate model and review of the literature. Can J Neurol Sci 1989;16:28-40
27. Zucker MB: A study of the substances in blood serum and platelets which stimulate smooth muscle. Am J Physiol 1944;142:12-26
28. Kapp J, Mahaley MS Jr, Odom GL: Cerebral arterial spasm: Part 2: Experimental evaluation of mechanical and humoral factors in pathogenesis. J Neurosurg 1968;29:339-349
29. Wilkins RH, Wilkins GK, Gunnells JC, Odom GL: Experimental studies of intracranial arterial spasm using aortic strip assays. J Neumsurg 1967;27:490-500
30. Starling LM, Boullin DJ, Grahame-Smith DHG, Adams CBT, Gye RS: Responses of isolated human basilar arteries to 5-hydroxytryptamine, noradrenaline, serum, platelets, and erythrocytes. J Neurol Neurosurg Psychiatry 1975;38:650-656
31. Ozaki N, Mullan S: Possible role of the erythrocyte in causing prolonged cerebral vasospasm. J Neurosurg 1979;51:773-778
32. Cheung ST, Mcllhany MP, Lim R, Mullan S: Preliminary characterization of vasocontractile activities in erythrocytes. J Neurosurg 1980;53:37-43
33. Handa H, Osaka K, Okamoto S: Breakdown products of erythrocytes as a cause of cerebral vasospasm, in Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins Co, 1980, pp 158-165
34. Ishii S, Ito M, Miyaoka M, Nonaka T: The causative factors of vasospasm and its treatment, in Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins Co, 1980, pp 556-565
35. Mcllhany MP, Johns LM, LeipzigT, Patronas NJ, Brown FD, Mullan SF: In vivo characterization of vasocon tractile activities in erythrocytes. J Neurosurg 1983;58:356-361
36. Okamoto S: Experimental study of cerebral vasospasm: Biochemical analysis of vasoconstrictor in the red blood cell hemorysate and the mechanism of action. Nippon Geka Hokan 1982;51:93-103
37. Wilkins RH, Levitt P: Intracranial arterial spasm in the dog: A chronic experimental model. J Neurosurg 1970;33:260-269
38. Weir B, Disney L, Grace M, Roberts P: Daily trends in white blood cell count and temperature after subarachnoid hemorrhage from aneurysm. Neurosurgery 1989;25:161-165
39. Jackson IJ: Aseptic hemogenic meningitis: An experimental study of aseptic meningeal reactions due to blood and its breakdown products. Arch Neurol Psychiatry 1949;62:572-589
40. Simmonds WJ: The absorption of blood from the cerebrospinal fluid in animals. Aust J Exp Biol Med Sci 1952;30:261-270
41. Endo S, Suzuki J: Experimental cerebral vasospasm after subarachnoid hemorrhage: Course and degree of vasospasm. Neurol Med Chir (Tokyo) 1977;17(part II):47-53
42. Peterson JW, Roussos L, Kwun BD, Hackett JD, Owen CJ, Zervas NT: Evidence of the role of hemolysts in experimental cerebral vasospasm. J Neurosurg 1990;72:775-781
43. Duff TA, Louie J, Feilbach JA, Scott G: Erythrocytes are essential for development of cerebral vasculopathy resulting from subarachnoid hemorrhage in cats. Stroke 1988;19:68-72
44. Nozaki K, Okamoto S, Yanamoto H, Kikuchi H: Red blood cells are essential for late vasospasra following experimentally induced subarachnoid hemorrhage in dogs. Neurol Med Chir (Tokyo) 1990;30:10-15
45. Mayberg MR, Okada T, Bark DH: The role of hemoglobin in arterial narrowing after subarachnoid hemorrhage. J Neurosurg 1990;72:634-640
46. Weir B, Grace M, Hansen J, Rothberg C: Time course of vasospasm in man. J Neurosurg 1978;48:173-178
47. Bcvan JA, Cutler SG, Schmidek HH: Chronic cerebral vasospasm is not due to active muscle contraction. Trends Pharmacol Sci 1986;7:345-346
48. Mayberg MR, Okada T, Bark DH: The significance of morphological changes in cerebral arteries after subarachnoid hemorrhage. J Neurosurg 1990;72:624-633
49. Mayberg MR, Okada T, Bark DH: Morphologic changes in cerebral arteries after subarachnoid hemorrhage, in Mayberg MR (ed): Neurosurgery Clinics of North America: Cerebral Vasospasm. Philadelphia, WB Saunders Co, 1990, pp 417-432
50. Bagley C Jn Blood in the cerebrospinal fluid: Resultant functional and organic alterations in the central nervous system: A: Experimental data. Arch Surg 1928;17:18-81
51. Hammes EM Jr: Reaction of the meninges to blood. Arch Neurol Psychiatry 1944;52:505-514
52. Alpers BJ, Forster FM: The reparative processes in subarachnoid hemorrhage. J Neuropathol Exp Neurol 1945;4: 262-268
53. Simmonds WJ: The absorption of labelled erythrocytes from the subarachnoid space in rabbits. Aust J Exp Biol Med Sci 1953;31:77-84
54. Adams JE, Prawirohardjo S: Fate of red blood cells injected into cerebrospinal fluid pathways. Neurology 1959;9:561-564
55. Dupont JR, van Wart CA, Kraintz L:The clearance of major components of whole blood from cerebrospinal fluid following simulated subarachnoid hemorrhage. J Neuropathol Exp Neurol 1961;20:450-455
56. Kronholm V, Lintrup J: Spectrophotometric investigations of the cerebrospinal fluid in the near-ultraviolet region. Acta Psychiatr Neurol Scand 1960;35:314-329
57. Van Der Meulen JP: Cerebrospinal fluid xanthochromia: An objective index. Neurology 1966;16:170-178
58. Wahlgren NG, Bergstrom K: Determination of haem derivatives in the cerebrospinal fluid: A semi-quantitative method. J Neurol Neurosurg Psychiatry 1983;46:653-658
59. Tourtellotte WW, Metz LN, Bryan ER, DeJong RN: Spontaneous subarachnoid hemorrhage: Factors affecting the rate of clearing of the cerebrospinal fluid. Neurology 1964;14:301-306
60. Vermeulen M, van Gijn J, Blijenberg BG: Spectrophotometric analysis of CSF after subarachnoid hemorrhage: Limitation in the diagnosis of rebleeding. Neurology 1983;33:112-114
61. Buckell M: Demonstration of substances capable of contracting smooth muscle in the haematoma fluid from certain cases of ruptured cerebral aneurysm. J Neurol Neurosurg Psychiatry 1964;27:198-199
62. Allen GS, Henderson LM, Chou SN, French LA: Cerebral arterial spasm: Part 2: In vitro contractile activity of serotonin in human serum and CSF on the canine basilar artery, and its blockage by methylsergide and phenoxybenzamine. J Neurosurg 1974;40:442-450
63. Allen GS, Gross CJ, French LA, Chou SN: Cerebral arterial spasm: Part 5: In vitro contractile activity of vasoactive agents including human CSF on human basilar and anterior cerebral arteries. J Neurosurg 1976;44:594-600
64. Boullin DJ, Mohan J, Grahame-Smith DG: Evidence for the presence of a vasoactive substance (possibly involved in the aetiology of cerebral arterial spasm) in cerebrospinal fluid from patients with subarachnoid hemorrhage. J Neurol Neurosurg Psychiatry 1976;39:756-766
65. Hunt TM, Du Boulay GH, Blaso WP, Forster DMC, Boullin DJ: Relationship between presence of vasoconstrictor activity in cerebrospinal fluid and time after subarachnoid haemorrhage from rupture of cerebral arterial aneurysms. J Neurol Neurosurg Psychiatry 1979;42:625-634
66. Blaso WP, Mistry G, Du Boulay GH, Forster DMC, Boullin DJ: The relationship of vasoactive substances in CSF of subarachnoid hemorrhage patients to cerebral vasospasm and prognosis, in Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Willdns Co, 1980, pp 144-157
67. Boullin DJ, Brandt L, Ljunggren B, Tagari P: Vasoconstrictor activity in cerebrospinal fluid from patients subjected to early surgery for ruptured intra cranial aneurysms. J Neurosurg 1981;55:237-245
68. Brandt L, Ljunggren B, Andersson KE, Hindfelt B, Teasdale G: Vasoconstrictive effects of human post-hemorrhagic cerebrospinal fluid on cat pial arterioles in situ. J Neurosurg 1981;54:351-356
69. Brandt L, Ljunggren B, Andersson KE, Hindfelt B: Individual variations in response of human cerebral arterioles to vasoactive substances, human plasma, and CSF from patients with aneurysmal SAH. J Neurosurg 1981;55:431-437
70. Okwuasaba F, Weir BKA, Cook DA, Krueger CA: Effects of various intracranial fluids on smooth muscle. Neurosurgery 1981;9:402-406
71. Costal M, Campero A, Rodriguez Rey R: Vasospastic activity of haemorrhagic CSF: Its effects “in vitro,” in Brock M (ed): Modern Neumsurgery I. Berlin, Springer-Verlag, 1982, pp 375-379
72. Tagari PC, Kaye AH, Teddy PJ, Schachter M, Adams CBT, Boullin DJ: The 5-hydroxytryptamine antagonist ketanserin inhibits the vasoconstrictor activity of per-operative CSF, from subarachnoid haemorrhage patients, on isolated tissues. J Neurol Neurosurg Psychiatry 1983;46:214-220
73. Kaye AH, Tagari PC, Teddy PJ, Adams CBT, Blaso WP, Boullin DJ: CSF smooth-muscle constrictor activity associated with cerebral vasospasm and mortality in SAH patients. J Neurosurg 1984;60:927-934
74. Sasaki T, Asano T, Takakura K, Sano K, Kassell NF: Nature of the vasoactive substance in CSF from patients with subarachnoid hemorrhage.JNeurosurg 1984;60:1186-1191
75. Yamamoto Y, Bernanke DH, Smith RR: Accelerated nonmuscle contraction after subarachnoid hemorrhage: Cerebrospinal fluid testing in a culture model. Neurosurgery 1990;27:921-928
76. Ohta T, Kajikawa H, Yoshikawa Y, Shimizu K, Funatsu N, Yamamoto M, Toda N: Cerebral vasospasm and hemoglobins: Clinical and experimental studies, in Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins Co, 1980, pp 166-172
77. White RP, MacLeod RM, Muhlbauer MS: Evaluation of the role hemoglobin in cerebrospinal fluid plays in producing contractions of cerebral arteries. Surg Neurol 1987;27:237-242
78. Wellum GR, Peterson JW, Zervas NT: The relevance of in vitro smooth muscle experiments to cerebral vasospasm. Stroke 1985;16:573-581
79. Cook DA: The pharmacology of cerebral vasospasm. Pharmacology 1984;29:1-16
80. Nagasawa S, Handa H, Naruo Y, Moritake K, Hayashi K: Experimental cerebral vasospasm: Arterial wall mechanics and connective tissue composition. Stroke 1982;13:595-600
81. Smith RR, Ctower BR, Grotendorst GM, Yabuno N, Cruse JM: Arterial wall changes in early human vasospasm. Neurosurgery 1985;16:171-176
82. Bevan JA, Bevan RD, Frazee JG: Functional arterial changes in chronic cerebrovasospasm in monkeys: An in vitro assessment of the contribution to arterial narrowing. Stroke 1987; 18:472-481
83. Fujii S, Fujitsu K: Experimental vasospasm in cultured arterial smooth-muscle cells: Pan 1: Contractile and ultrastructural changes caused by oxyhemoglobin. J Neurosurg 1988;69:92-97
84. Steele JA, Stockbridge N, Maljkovic G, Weir B: Free radicals mediate actions of oxyhemoglobin on cerebrovascular smooth muscle cells. Ore Res 1990;68:416-423
85. Cook DA, Weir BKA, Okwuasaba FK, Krueger CA: Effects of hemoglobin on smooth muscle. Proc West Pharmacol Soc 1979;22:429-434
86. Tanishima T: Cerebral vasospasm: Contractile activity of hemoglobin in isolated canine basilar arteries. J Neurosurg 1980;53:787-793
87. Toda N, Shimizu K, Ohta T: Mechanism of cerebral arterial contraction induced by blood constituents. J Neurosurg 1980;53:312-322
88. Wellum GR, Irvine TW Jr, Zervas NT: Dose responses of cerebral arteries of the dog, rabbit, and man to human hemoglobin in vitro. J Neurosurg 1980;53:486-490
89. 2 to vasoconstrictions induced by various prostaglandins, serotonin, and hemoglobin using the canine basilar artery. Neurol Med Chir (Tokyo) 1982;22:507-512
90. Fujita Y, Shingu T, Yamada K, Araki O, Matsunaga M, Mori K, Kawano T: Noxious free radicals derived from oxyhemoglobin as a cause of prolonged vasospasm. Neurol Med Chir (Tokyo) 1980;20:137-144
91. Wellum GR, Irvine TW Jr, Zervas NT: Cerebral vasoactrvity of heme proteins in vitro: Some mechanistic considerations. J Neurosurg 1982;56:777-783
92. Fukumori T, Tani E, Maeda Y, Sukenaga A: Effects of prostacyclin and indomethacin on experimental delayed cerebral vasospasm. J Neurosurg 1983;59:829-834
93. Tanishima T: Cerebral vasospasm: Comparison of contractile responses in isolated human and canine basilar arteries. No To Shinkei 1983;35:323-329
94. Okamoto S, Handa H, Toda N: Role of intrinsic arachidonate metabolites in the vascular action of erythrocyte breakdown products. Stroke 1984;15:60-64
95. Fujiwara S, Kassell NF, Sasaki T, Nakagomi T, Lehman RM: Selective hemoglobin inhibition of endothelium-dependent vasodilation of rabbit basilar artery. J Neurosurg 1986;64:445-452
96. Connor HE, Feniuk W: Role of endothelium in haemoglobin-induced contraction of dog basilar artery. Eur J Pharmacol 1987;140:105-108
97. Hongo K, Kassell NF, Nakagomi T, Sasaki T, Tsukahara T, Ogawa H, Vollmer D, Lehman RM: Subarachnoid hemorrhage inhibition of endothelium-derived relaxing factor in rabbit basilar artery. J Neurosurg 1988;69:247-253
98. Nakagomi T, Kassell NF, Lehman RM, Jane JA, Sasaki T, Takakura K: Endothelial damage and cerebral vasospasm, in Wilkins RH (ed): Cerebral Vasospasm. New York, Raven Press, Publishers, 1988, pp 137-143
99. Nakagomi T, Kassell NF, Lehman RM, Hongo K, Jane JA, Sasaki T, Takakura K: Hypoxia and cerebral vasospasm, in Wilkins RH (ed): Cerebral Vasospasm. New York, Raven Press, Publishers, 1988, pp 317-322
100. Nakagomi T, Kassell NF, Sasaki T, Lehman RM, Tomer JC, Hongo K, Lee JF: Effect of removal of the endothelium on vasocontraction in canine and rabbit basilar arteries. J Neurosurg 1988;68:757-766
101. Okamoto S, Kikuchi H, Handa Y, Handa H: Responses of fresh human, monkey, and canine cerebral arteries to a red blood cell hemotysate, in Wilkins RH (ed): Cerebral Vasospasm. New York, Raven Press, Publishers, 1988, pp 311-316
102. Tanaka Y, Chiba S: Potentiating effects of extraluminal oxyhemoglobin to intraluminal 5-hydroxytryptamine in isolated canine internal carotid arteries, J Neurosurg 1988;69:263-268
103. Nakayama K, Tanaka Y, Fujishima K: Potentiation of stretch-induced myogenic tone of dog cerebral artery by hemolysate and the inhibitory action of calcium antagonists. Eur J Pharmacol 1989;169:33-42
104. Tsuji T, Weir BKA, Cook DA: Time-dependent effects of extraluminally-applied oxyhemoglobin and endothelial removal on vasodilator responses in isolated, perfused canine basilar arteries. Pharmacology 1989;38:101-112
105. Chokyu M: An experimental study of cerebral vasospasm, especially on spasmogenic factors in red blood cells. Osaka City Med J 1975;24:211-221
106. Fox JL: IntracTanial vasospasm: A study with iron compounds. Surg Neurol 1979;11:363-368
107. Ohmoto T, Yoshioka J, Shibata K, Morooka H, Matsumoto Y, Nishimoto A; Cerebral vasospasm following subarachnoid hemorrhage: Experimental and clinical studies. Neurol Med Chir (Tokyo) 1979;19:73-81
108. Kajikawa H, Ohta T, Yoshikawa Y, Funatsu N, Yamamoto M, Someda K: Cerebral vasospasm and hemoglobins: Clinical and experimental studies. Neurol Med Chir (Tokyo) 1979;19:61-71
109. Ohta T, Kajikawa H, Funatsu N, Yoshikawa Y, Someda K: Cerebral vasospasm and its relaxation responses to vasodilators: Pathological study of severe prolonged vasospasm, in Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins Co, 1980, pp 132-138
110. Kamiyama K, Okada H, Suzuki J: The relation between cerebral vasospasms and superoxide: Application of an experimental model of vasospasms induced by oxyhemoglobin in cats. Neurol Med Chir (Tokyo) 1981;21:201-209
111. Quintana L, Konda R, Ishibashi Y, Yoshimoto T, Suzuki J: The effect of prostacyclin on cerebral vasospasm: An experimental study. Acta Neurochir (Wien) 1982;62:187-193
112. Iwai R, Kamiyama K, Nagahori T, Ohtsuji T, Endo S, Takaku A: Relation of supersensitivity to cerebral vasospasm induced by oxyhaemoglobin. Neurol Res 1988;10:169-174
113. Byrne JV, Griffith TM, Edwards DH, Harrison TJ, Johnston KR: Investigation of the vasoconstrictor action of subarachnoid haemoglobin in the pig cerebral circulation in vivo. BrJ Pharmacol 1989;97:669-6 74
114. Nonaka T: Experimental and clinical studies of treatment for prolonged vasospasm. Proc Jpn Surg Soc 1977;78:359-375
115. Yoshida Y: Experimental studies on fibrinohytic activity and angiospasm following subarachnoid hemorrhage in dogs. Nippon Geka Hokan 1978;47:537-562
116. Nonaka T, Watanabe S, Chigasaki H, Miyaoka M, Ishii S: Etiology and treatment of vasospasm following subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 1979;19:53-60
117. Boullin DJ, Tagari P, Du Boulay G, Aitken V, Hughes JT: The role of hemoglobin in the etiology of cerebral vasospasm: An in vivo study of baboons. J Neurosurg 1983;59:231-236
118. White RP: Pharmacodynamic features of delayed cerebral vasospasm, in Wilkins RH (ed): Cerebral Vasospasm. New York, Raven Press, Publishers, 1988, pp 373-382
119. Fujiwara S, Kuriyama H: Hemohlysate-induced contraction in smooth muscle cells of the guinea pig basilar artery. Stroke 1984;15:503-510
120. Kanamaru K, Waga S, Kojima T, Fujimoto K, Niwa S: Endothelium-dependent relaxation of canine basilar arteries: Part 2: Inhibition by hemoglobin and cerebrospinal fluid from patients with aneurysmal subarachnoid hemorrhage. Stroke 1987;18:938-943
121. Onoue H, Nakamura N, Toda N: Prolonged exposure to oxyhemoglobin modifies the response of isolated dog middle cerebral arteries to vasoactive substances. Stroke 1989;20:657-663
122. Espinosa F, Weir B, Overton T, Castor W, Grace M, Boisvert D: A randomized placebo-controlled double-blind trial of nimodipine after SAH in monkeys: Part 1: Clinical and radiological findings. J Neurosurg 1984;60:1167-1175
123. Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Chou SN, Kelly DL, Weir BK, Crabbe RA, Lavik PJ, Rosenbloom SB, Dorsey FC, Ingram CR, Mellits DE, Bertsch LA, Boisvert DPJ, Hundley MB, Johnson RK, Strom JA, Transou CR: Cerebral arterial spasm: Controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med 1983;308:619-624
124. Petruk KC, West M, Mohr G, Weir BKA, Benoit BG, Gentili R, Disney LB, Khan MI, Grace M, Holness RO, Karwon MS, Ford RM, Cameron GS, Tucker WS, Purves GB, Miller JDR, Hunter KM, Richard MT, Durity FA, Chan R, Clein LJ, Maroun FB, Godon A: Nimodipine treatment in poor-grade aneurysm patients: Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 1988;68:505-517
125. Vollrath B, Weir BKA, Cook DA: Hemoglobin causes release of inositol trisphosphate from vascular smooth muscle. Biochem Biophys Res Common 1990;171:506-511
126. Walker V, Pickard JD: Prostaglandins, thromboxane, leukotrienes and the cerebral circulation in health and disease. Adv Tech Stand Neurosurg 1985;12:3-90
127. Sasaki T, Murota S, Wakai S, Asano T, Sano K: Evaluation of prostaglandin biosynthetic activity in canine basilar artery following subarachnoid injection of blood. J Neurosurg 1981;55:771-778
128. Maeda Y, Tani E, Miyamoto T: Prostaglandin metabolism in experimental cerebral vasospasm. J Neurosurg 1981;55:779-785
129. Tokoro K: Cerebral vasospasm and lipoperoxide damage: Morphological localization and measurement of lipoperoxide in prolonged cerebral vasospasm. No Shinkd Geka 1984;12:1049-1058
130. 2 in cerebral arteries of the monkey. Neurosurgery 1988;22:45-50
131. Rodriguez y Baena R, Gaetani P, Silvani V, Vigano T, Crivellari MT, Paoletti P: Cisternal and lumbar CSF levels of arachidonate metabolites after subarachnoid haemorrhage: An assessment of the biochemical hypothesis of vasospasm. Acta Neurochir (Wien) 1987;84:129-135
132. 2 in patients with subarachnoid hemorrhage. Surg Neurol 1987;27:243-252
133. Chehrazi BB, Giri S, Joy RM: Prostaglandins and vasoactive amines in cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 1989;20:217-224
134. Okamoto S, Handa H, Handa Y: Hemolysate-induced release of prostaglandinlike substances from the canine cerebral arteries. Surg Neurol 1985;23:421-424
135. Toda N: Hemolysate inhibits cerebral artery relaxation. J Cereb Blood Flow Metab 1988;8:46-53
136. Sasaki T, Wakai S, Asano T, Takakura K, Sano K: Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581. J Neurosurg 1982;57:74-82
137. 2 synthetase on experimental cerebral vasospasm. Stroke 1984;15:306-311
138. 2 synthetase on cerebral vasospasm after early surgery. J Neurosurg 1984;61:24-29
139. Suzuki S, Iwabuchi T, Tanaka T, Kanayama S, Otiomo M, Hatanaka M, Aihara H: Prevention of cerebral vasospasm with OKY-046 an imidazole derivative and a thromboxane synthetase inhibitor: A preliminary co-operative clinical study. Acta Neurochir (Wien) 1985;77:133-141
140. Nishiye E, Nakao K, Itoh T, Kuriyama H: Factors inducing endothelium-dependent relaxation in the guinea-pig basilar artery as estimated from the actions of haemoglobin. Br J Pharmacol 1989;96:645-655
141. Paoletti P, Gaetani P, Grignani B, Pacchiarini L, Silvani V, Rodriguez y Baena R: CSF leukotriene C following subarachnoid hemorrhage. J Neurosurg 1988;69:488-493
142. Shimizu T, Watanabe T, Asano T, Seyama Y, Takakura K: Activation of the arachidonate 5-lipoxygenase pathway in the canine basilar artery after experimental subarachnoid al hemorrhage, J Neurochem 1988;51:1126-1131
143. Yokota M, Tani E, Maeda Y: Biosynthesis of leukotrienes in canine cerebral vasospasm. Stroke 1989;20:527- 533
144. Wever R, Oudega B, van Gelder BF: Generation of superoxide radicals during the autoxidation of mammalian oxyhemoglobin. Biochim Biophys Acta 1973;302:475-478
145. Koide T, Noda Y, Hata S, Sugioka K, Kobayashi S, Nakano M: Contraction of the canine basilar artery following linoleic, arachidonic, 13-hydroperoxylinoleic, or 15-hydroper-oxyarachidonic acid (41294). Proc Soc Exp Biol Med 1981;168:399-402
146. Koide T, Neichi T, Takato M, Matsushita H, Sugioka K, Nakano M, Hata SI: Possible mechanisms of 15-hydroperoxyarachidonic acid-induced contraction of the canine basilar artery in vitro. J Pharmacol Exp Ther 1982;221:481-488
147. Sasaki T, Asano T, Sano K: Cerebral vasospasm and free radical reactions. Neurol Med Chir (Tokyo) 1980;20:145-153
148. Sasaki T, Wakai S, Asano T, Watanabe T, Kirino T, Sano K: The effect of a lipid hydroperoxide of arachidonic acid on the canine basilar artery: An experimental study on cerebral vasospasm. J Neurosurg 1981;54:357-365
149. Sasaki S, Kuwabara H, Ohta S: Biological defence mechanism in the pathogenesis of prolonged cerebral vasospasm in the patients with ruptured intracranial aneurysms. Stroke 1986;17:196-202
150. Watanabe T, Sasaki T, Asano T, Takakura K, Sano K, Fuchinoue T, Watanabe K, Yoshimura S, Abe K: Changes in glutathione percoridase and lipid peroxides in cerebrospinal fluid and serum after subarachnoid hemorrhage: With special reference to the occurrence of cerebral vasospasm. Neural Med Our (Tokyo) 1988;28:645-649
151. Steinke DE, Weir BKA, Findlay JM, Tanabe T, Grace M, Krushelnycky BW: A trial of the 21-aminosteroid U74006F in a primate model of chronic cerebral vasospasm. Neurosurgery 1989;24:179-186
152. Halliwell B, Gutteridge JMC: Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts. Arch Biochem Biophys 1986;246:501-514
153. Suzuki N, Nakamura T, Imabayashi S, Ishikawa Y, Sasaki T, Asano T: Identification of 5-hydroiy eicosatetraenoic acid in cerebrospinal fluid after subarachnoid hemorrhage. J Neurochem 1983;41:1186-1189
154. Fisher CM, Kistler JP, Davis JM: Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 1980;6:1-9
155. Clemens MR, Einsele H, Remmer H, Waller HD: An essential requirement for ferrous-haemoglobin in the hydrogen peroxide stimulated oxidation of red blood cell membrane lipids. Biochem Pharmacol 1985;34:1339-1341
156. Hallrwell B, Gutteridge JMC: Oxygen free radicals and the nervous system. Trends Neurosci 1985;8:22-26
157. Tappcl AL: Lipid peroxidation damage to cell components. Fed Proc 1973;31:1870-1874
158. Vladimirov YA, Olenev VI, Suslova TB, Cheremisina ZP: Lipid peroxidation in mitochondrial membrane. Adv Lipid Res 1980;17:173-249
159. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376
160. Angus JA, Cocks TM: Endothelium-derived relaxing factor. Pharmacol Ther 1989;41:303-352
161. Kim P, Sundt TM Jr, Vanhoutte PM: Alterations in endothelium-dependent responsiveness of the canine basilar artery after subarachnoid hemorrhage. J Neurosurg 1988;69:239-246
162. Kim P, Lorenz RR, Sundt TM Jr, Vanhoutte PM: Release of endothelium-derived relaxing factor after subarachnoid hemorrhage. J Neurosurg 1989;70:108-114
163. Nakagomi T, Kassell NF, Sasaki T, Fujiwara S, Lehman RM, Johshita H, Nazar GB, Tomer JC: Effect of subarachnoid hemorrhage on endothelium-dependent vasodilation. J Neurosurg 1987;66:915-923
164. Nakagomi T, Kassell NF, Sasaki T, Fujiwara S, Lehman RM, Torner JC: Impairment of endothelium-dependent vasodilation induced by acetylcholine and adenosine triphosphate following experimental subarachnoid hemorrhage. Stroke 1987;18:482-489
165. Kanamaru K, Weir BKA, Findlay JM, Krueger CA, Cook DA: Pharmacological studies on relaxation of spastic primatecerebral arteries in subarachnoid hemorrhage. J Neurosurg 1989;71:909- 915
166. Martin W, Villani GM, Jothianandan D, Furchgott RF: Blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation of rabbit aorta by certain ferrous hemoproteins. J Pharmacol Exp Ther 1985;233:679-685
167. Edwards DH, Griffith TM, Ryley HC, Henderson AH: Haptoglobin-haemoglobin complex in human plasma inhibits endothelium dependent relaxation: Evidence that endothelium derived relaxing factor acts as a local autocoid. Cardiovasc Res 1986;20:549-556
168. Stewart DJ, Munzcl T, Bassenge E: Reversal of acetylcholine-induced coronary resistance vessel dilation by hemoglobin. Eur J Pharmacol 1987;136:239-242
169. Chen G, Suzuki H, Weston AH: Acetycholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol 1988;95:1165-1174
170. Hongo K, Ogawa H, Kassell NF, Nakagomi T, Sasaki T, Tsukahara T, Lehman RM: Comparison of intraluminal and extraluminal inhibitory effects of hemoglobin on endothelium-dependent relaxation of rabbit basilar artery. Stroke 1988;19:1550-1555
171. Tanaka Y, Chiba S: Relationship between extraluminal oxyhemoglobin and endothelium-dependent vasodilatation in isolated perfused canine internal carotid arteries. Neurosurgery 1988;23:158-161
172. Toda N, Minami Y, Onoue H: Extraluminalry applied acetylcholine and oxyhemoglobin on the release and action of EDRF. Eur J Pharmacol 1988;151:123-126
173. Iinnik MD, Lee TJF: Effect of hemoglobin on neurogenic responses and cholinergic parameters in porcine cerebral arteries. J Cereb Blood Flow Metab 1989;9:219-225
174. Findlay JM, Weir BKA, Kanamaru K, Espinosa F: Arterial wall changes in cerebral vasospasm. Neurosurgery 1989;25:736-746
175. Gibson QH, Roughton FJW: The kinetics of equilibria of the reactions of nitric oxide with sheep haemoglobin. J Physiol 1957;136:507-526
176. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415
177. Shigeno T, Mima T, Takakura K, Yanagisawa M, Saito A, Fujimori A, Goto K, Masaki T: Role of endothelin in cerebral vasospasm, in Sano K, Takakura K, Kassell NF, Sasaki T (eds): Cerebral Vasospasm. Tokyo, University of Tokyo Press, 1990, pp 250-252
178. Masaoka H, Suzuki R, Hirata Y, Emori T, Marumo F, Hirakawa KJ Raised plasma and cerebrospinal fluid endothelin in aneurysmal subarachnoid hemorrhage, in Sano K, Takakura K, Kassell NF, Sasaki T (eds): Cerebral Vasospasm. Tokyo, University of Tokyo Press, 1990, pp 266-268
179. Sato S, Ishihara N, Yunoki K, Nakamigawa T, Oohira T, Takayama H, Toya S, Suzuki H, Shimoda S: The changes in endothelin concentration in CSF following subarachnoid hemorrhage, in Sano K, Takakura K, Kassell NF, Sasaki T (eds): Cerebral Vasospasm. Tokyo, University of Tokyo Press, 1990, pp 269-271
180. Elliott DA, Ong BY, Bruni JE, Bose D: Role of endothelium in hypoxic contraction of canine basilar artery. BrJ Pharmacol 1989;96:949-955
181. Kjellin KG: The binding of xanthochromic compounds in the cerebrospinal fluid: Preliminary report. J Neurol Sci 1969;9:597-601
182. Kjellin KG: Bilirubin compounds in the CSF. J Neurol Set 1971;13:161-173
183. Stocker R, Glazer AN, Ames BN: Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci USA 1987;84:5918-5922
184. Plum F, Posner JB: The Diagnosis of Stupor and Coma, ed 3. Philadelphia, FA Davis Co, 1982, pp 224-225
185. Stocker R, Ames BN: Potential role of conjugated bilirubin and copper in the metabolism of lipid peroxides in bile. Proc Natl Acad Sci USA 1987;84:8130-8134
186. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN: Bilirubin is an antioxidant of possible physiological importance. Science 1987;235:1043-1046
187. Wahlgren NG, Lindquist C: Haem derivatives in subdural haematomas. Acta Neurochir (Wien) 1988;95:109-113
188. Edvinsson L, Owman C: Cerebrovasculai nerves and vasomotor receptors, in Wilkins RH (ed): Cerebral Arterial Spasm. Baltimore, Williams & Wilkins Co, 1980, pp 30-36
189. Svendgaard NA, Delgado TJ, Arbab MAR: Catecholaminergic and peptidergic systems underlying cerebral vasospasm: CBF and CMRgl changes following an experimental subarachnoid hemorrhage in the rat, in Wilkins RH (ed): Cerebral Vasospasm. New York, Raven Press, Publishers, 1988, pp 175-186
190. Gaw AJ, Wadsworth RM, Humphrey PPA: Neurotransmission in the sheep middle cerebral artery: Modulation of responses by 5-HT and haemolysate. J Cereb Blood Flow Metab 1990;10:409-416
191. Duff TA, Scott G, Feilbach JA: Ultrastructural evidence of arterial denervation following experimental subarachnoid hemorrhage. J Neurosurg 1986;64:292-297
192. Peerless SJ, Yasargil MG: Adrenergic innervation of the cerebral blood vessels in the rabbit. J Neurosurg 1971;35:148-154
193. Delgado TJ, Brismar J, Svendgaard NA: Subarachnoid haemorrhage in the rat: Angiography and fluorescence microscopy of the major cerebral arteries. Stroke 1985;16:595-602
194. Lobato RD, Marin J, Salaices M, Burgos J, Rivilla F, Garcia AG: Effect of experimental subarachnoid hemorrhage on the adrenergic innervation of cerebral arteries. J Neurosurg 1980;53:477-479
195. Hara H, Nosko M, Weir B: Cerebral perivascular nerves in subarachnoid hemorrhage: A histochemical and immunohistochemical study. J Neurosurg 1986;65:531-539
196. Nagai H, Noda S, Mabe H: Experimental cerebral vasospasm: Part 2: Effects of vasoactive drugs and sympathectomy on early and late spasm. J Neurosurg 1975;42:420-428
197. Suzuki J, Iwabuchi T, Hori S: Cervical sympathectomy for cerebral vasospasm after aneurysm rupture. Neurol Med Chir (Tokyo) 1975;15:41-50
198. Wilkins RH: Attempts at prevention or treatment of intracranial arterial spasm: An update. Neurosurgery 1986;18:808-825
199. Lee TJF, Mcllhany MP, Sarwinski S: Erythrocyte extracts enhance neurogenic vasoconstriction of dog cerebral arteries in vitro. J Cereb Blood Flow Metab 1984;4:474-476
200. Kim P, Sundt TM Jr, Vanhoutte PM: Alterations of mechanical properties in canine basilar arteries after subarachnoid hemorrhage. J Neurosurg 1989;71:430-436
201. Vorkapic P, Bevan RD, Bevan JA: Pharmacologic irreversible narrowing in chronic cerebrovasospasm in rabbits is associated with functional damage. Stroke 1990;21:1478-1484